Search - tctmd.com

Displaying 201 - 220 of 841

Sort: Relevancy | Date

News Daily News

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

Todd Neale

March 16, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

News Daily News

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Michael O'Riordan

March 08, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

News Daily News

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

L.A. McKeown

March 04, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

News Daily News

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Michael O'Riordan

February 16, 2022

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

L.A. McKeown

February 15, 2022

News Daily News

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

Michael O'Riordan

January 28, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

Caitlin E. Cox

January 25, 2022

News Daily News

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

Yael L. Maxwell

January 24, 2022

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

News Daily News

‘Home Time’ Validated as TAVI Outcomes Performance Metric

L.A. McKeown

January 11, 2022

News Daily News

Studies Zero in on Delayed Conduction Problems After TAVI

Todd Neale

December 21, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Daily News

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

L.A. McKeown

December 20, 2021

Advertisement

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Robert M. Califf Becomes 25th Commissioner of the US FDA

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

‘Home Time’ Validated as TAVI Outcomes Performance Metric

Studies Zero in on Delayed Conduction Problems After TAVI

FDA Approves Two Additional Indications for Rivaroxaban in Children

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content